Wei‐Yun Lai

1.5k citations

29 papers · 1.1k indexed · h-index 18

Co-authors: Pan‐Chyr Yang Hung-Wen Tsai Hsing‐Wen Sung Yen Chang Mei‐Chin Chen Emily Lin Shu‐Fen Peng Ming‐You Shie
Topics: Cancer, Hypoxia, and Metabolism (6 papers)Neuroblastoma Research and Treatments (6 papers)Advanced biosensing and bioanalysis techniques (4 papers)
Cited by: Biomaterials Polymers and Plastics Cancer Research
Journals: Proceedings of the National Academy of Sciences Nature Communications Journal of Clinical Oncology
Partner nations: Taiwan Sweden Belgium

In The Last Decade

Wei‐Yun Lai

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Wei‐Yun Lai

Since Specialization

Citations

This map shows the geographic impact of Wei‐Yun Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Yun Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Yun Lai more than expected).

Fields of papers citing papers by Wei‐Yun Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Yun Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Yun Lai. The network helps show where Wei‐Yun Lai may publish in the future.

Co-authorship network of co-authors of Wei‐Yun Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Yun Lai. A scholar is included among the top collaborators of Wei‐Yun Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Yun Lai. Wei‐Yun Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth 2024 ·Cell Death and Differentiation ·Wei‐Yun Lai,(unknown),(unknown),(unknown),Bengt Hallberg,Ruth H. Palmer	6
2	AptBCis1, An Aptamer–Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis 2024 ·ACS Nano ·(unknown),Wei‐Yun Lai,(unknown),(unknown),Konan Peck,Pan‐Chyr Yang,(unknown)	8
3	ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression 2023 ·Proceedings of the National Academy of Sciences ·(unknown),Wei‐Yun Lai,(unknown),(unknown),Ganesh Umapathy,(unknown),Bengt Bergman,(unknown),Fredrik B. Thorén,Anh T. Le,Robert C. Doebele,Jimmy Van den Eynden,Ruth H. Palmer,Bengt Hallberg	15
4	Abstract 3544: ALK signaling activity stabilizes SLC3A2 protein levels in neuroblastoma tumorigenesis 2023 ·Cancer Research ·Wei‐Yun Lai,(unknown),(unknown),Ruth H. Palmer,Bengt Hallberg	0
5	ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition 2023 ·Proceedings of the National Academy of Sciences ·(unknown),Ganesh Umapathy,(unknown),Wei‐Yun Lai,Jikui Guan,(unknown),Eva Jennische,Alexander Schmidt,Yeshwant Kurhe,(unknown),(unknown),Anneli Strömberg,Mats Bemark,Michael N. Hall,Jimmy Van den Eynden,Bengt Hallberg,Ruth H. Palmer	6
6	Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC 2022 ·Lung Cancer ·(unknown),Wei‐Yun Lai,Anh T. Le,(unknown),(unknown),Susanne Fransson,Bengt Bergman,Anna Djos,(unknown),Tommy Martinsson,Jimmy Van den Eynden,Robert C. Doebele,Ruth H. Palmer,Bengt Hallberg,Ganesh Umapathy	7
7	PINK1-Mediated Inhibition of EGFR Dimerization and Activation Impedes EGFR-Driven Lung Tumorigenesis 2021 ·Cancer Research ·(unknown),(unknown),Wei‐Yun Lai,(unknown),Shuenn‐Chen Yang,(unknown),Pan‐Chyr Yang	1
8	ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation 2021 ·The EMBO Journal ·(unknown),Ganesh Umapathy,Wei‐Yun Lai,(unknown),Barbara Witek,Jikui Guan,Patricia Mendoza-García,(unknown),A. Claeys,(unknown),Abeer El Wakil,Badrul Arefin,Susanne Fransson,Jan Köster,(unknown),(unknown),Jimmy Van den Eynden,Bengt Hallberg,Ruth H. Palmer	33
9	11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma 2020 ·Cell Reports ·(unknown),Niloufar Javanmardi,Jimmy Van den Eynden,(unknown),Susanne Fransson,(unknown),Anna Djos,Rose‐Marie Sjöberg,Malin Östensson,Helena Carén,Gunhild Trøen,Klaus Beiske,Ana P. Berbegall,Rosa Noguera,Wei‐Yun Lai,Per Kogner,Ruth H. Palmer,Bengt Hallberg,Tommy Martinsson	28
10	A Novel TNF-α-Targeting Aptamer for TNF-α-Mediated Acute Lung Injury and Acute Liver Failure 2019 ·Theranostics ·Wei‐Yun Lai,(unknown),(unknown),Emily Lin,Pan‐Chyr Yang	110
11	A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect 2017 ·Molecular Therapy — Nucleic Acids ·(unknown),Wei‐Yun Lai,(unknown),(unknown),Shauh-Der Yeh,Emily Lin,Pan‐Chyr Yang	55
12	Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis 2016 ·Nature Communications ·Ching-Wen Lin,(unknown),Shu‐Ping Wang,Yih‐Leong Chang,Yi-Ying Wu,Hsuan‐Yu Chen,Tzu-Hung Hsiao,Wei‐Yun Lai,Hsuan‐Hsuan Lu,Ya-Hsuan Chang,Shuenn-Chen Yang,Ming‐Wei Lin,Chi‐Yuan Chen,Tse‐Ming Hong,Pan‐Chyr Yang	76
13	A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects 2016 ·Molecular Therapy — Nucleic Acids ·Wei‐Yun Lai,(unknown),(unknown),(unknown),Pan‐Chyr Yang	136
14	Fluorescence-Guided Probes of Aptamer-Targeted Gold Nanoparticles with Computed Tomography Imaging Accesses for in Vivo Tumor Resection 2015 ·Scientific Reports ·(unknown),Tsung‐Rong Kuo,(unknown),Wei‐Yun Lai,Pan‐Chyr Yang,Jinn-Shiun Chen,Di‐Yan Wang,Yi‐Chun Wu,Chia‐Chun Chen	91
15	An evaluation of the inflammatory response of lipopolysaccharide-treated primary dental pulp cells with regard to calcium silicate-based cements 2014 ·International Journal of Oral Science ·Wei‐Yun Lai,Chia‐Tze Kao,Chi-Jr Hung,Tsui‐Hsien Huang,Ming‐You Shie	30
16	Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimeras 2014 ·Biomaterials ·Wei‐Yun Lai,(unknown),Yeun‐Chung Chang,(unknown),Pan‐Chyr Yang,Konan Peck	60
17	CSNK1E/CTNNB1 Are Synthetic Lethal To TP53 in Colorectal Cancer and Are Markers for Prognosis 2014 ·Neoplasia ·(unknown),(unknown),Kun‐Tu Yeh,Ting‐Yuan Liu,Jia‐Hong Wu,(unknown),Shu‐Hui Lin,Wei‐Yun Lai,Yu‐Chin Hsu,Jeou-Yuan Chen,Jan‐Gowth Chang,Grace S. Shieh	21
18	Overcoming EGFR T790M-based Tyrosine Kinase Inhibitor Resistance with an Allele-specific DNAzyme 2014 ·Molecular Therapy — Nucleic Acids ·Wei‐Yun Lai,Chi‐Yuan Chen,Shuenn‐Chen Yang,Jer‐Yuarn Wu,(unknown),Pan‐Chyr Yang,Konan Peck	3
19	A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs 2009 ·Biomaterials ·Mei‐Chin Chen,Hung-Wen Tsai,(unknown),Shu‐Fen Peng,Wei‐Yun Lai,(unknown),Yen Chang,Hsing‐Wen Sung	67
20	The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents 2008 ·Biomaterials ·Mei‐Chin Chen,Yen Chang,(unknown),Wei‐Yun Lai,Shu‐Fen Peng,Yi-Wen Hung,Hung-Wen Tsai,Hsing‐Wen Sung	53

About Wei‐Yun Lai

Wei‐Yun Lai is a scholar working on Oral Surgery, Orthodontics and Cancer Research, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (6 papers), Neuroblastoma Research and Treatments (6 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Biomaterials (208 citations), Polymers and Plastics (117 citations) and Cancer Research (119 citations). Wei‐Yun Lai has collaborated with scholars based in Taiwan, Sweden and Belgium. Frequent co-authors include Pan‐Chyr Yang, Hung-Wen Tsai, Hsing‐Wen Sung, Yen Chang, Mei‐Chin Chen, Emily Lin, Shu‐Fen Peng, Ming‐You Shie, Fwu‐Long Mi and Tsung‐Rong Kuo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact